The pragmatic path is measurement and small habit experiments, not guessing
Lower credit cost with measurable impact
However, if you complain about these things to your family doctor, or general practitioner, do not be surprised if he or she tells you you are just getting older, deal with it. That is because general practitioners are not as familiar with the many benefits of growth hormone therapy as are our doctors and age-management professionals
Weight regain (around 6.0% of original body weight in the semaglutide group and 1.4% in the placebo group) occurred in the 28 weeks following treatment discontinuation, such that the mean change in body weight from baseline was 7.9% for semaglutide 2.4 mg and 1.3% for placebo, with an ongoing upward trend at the end of 80 weeks
Between 1985 and 1987, Svetlana Mojsov identified the biologically active fragment of GLP-1, and Mojsov, Joel Habener, Daniel Drucker, and Jens Juul Holst proved it stimulates insulin secretion
It is not approved by the FDA, EMA, MHRA, PMDA, or any other regulatory authority for any therapeutic indication
